[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100427656":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":18,"centralContacts":23,"locations":32,"responsibleParty":49,"collaborators":51,"id":54,"slug":10,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":66,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Universitätsklinikum Hamburg-Eppendorf","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Patient transplanted due to ACHD and heart failure",null,"Patients successfully transplanted due to congenital heart failure.",{"label":13,"type":10,"description":14,"interventionNames":10},"ACHD listed due to heart failure for heart or heart and combined organ transplantation","Patients on the actual waiting list for heart or heart and combined organ transplantation. They can have either outcome transplantation or the primary outcome death on the waiting list or delisting due to clinical worsening. The secondary outcome is as well delisting due to clinical improvement.",{"label":16,"type":10,"description":17,"interventionNames":10},"ACHD evaluated for heart transplantation","All patients evaluated for heart or heart and combined organ transplantation at the hospital level",[19],{"name":20,"affiliation":21,"role":22},"Christoph Sinning, MF","University Heart & Vascular Center Hamburg","PRINCIPAL_INVESTIGATOR",[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Christoph Sinning, MD","CONTACT","004915222817675","c.sinning@uke.de",{"name":30,"role":26,"phone":10,"phoneExt":10,"email":31},"Christina Magnussen, MD","c.magnussen@uke.de",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"University Heart and Vascular Center Hamburg","RECRUITING","Hamburg","Free and Hanseatic City of Hamburg","20246","Germany",{"type":41,"coordinates":42},"Point",[43,44],9.99302,53.55073,{"lat":44,"lon":43},[47,48],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":30,"role":26,"phone":10,"phoneExt":10,"email":31},{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[52],{"name":53,"class":6},"Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)","100427656",false,"NCT04848844","The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)","The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R): A Global Register to Investigate Factors Associated With Morbidity and Mortality in Adult Patients With Congenital Heart Disease (ACHD) on the Waiting List for Heart or Heart\u002FLung Transplantation","ARTORIA-R","Inclusion Criteria:\n\n1. The patient has to be listed as an adult transplant candidate in the country the data is obtained with an age ≥18 years\n2. The patient has to have a congenital heart defect or an inherited cardiomyopathy (specific; hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy or non-compaction cardiomyopathy) which is often included into the category ACHD\n3. Data is obtained from the first evaluation for listing or listing for heart-only or heart-combined organ transplantation\n4. Transfer of anonymised data\n5. The institution\u002Forganization agrees to the memorandum how data is managed, and scientific cooperation is planned between all institutions\n\nExclusion Criteria:\n\na. The patient is listed for a second heart transplantation (retransplantation)","ALL","18 Years",{"count":64,"type":65},2000,"ESTIMATED","30 Years","OBSERVATIONAL","Advances in surgical and medical care have led to improved outcomes in patients with congenital heart disease (CHD). As a consequence, the majority of patients nowadays survives to adulthood (adults with CHD, that is, adult CHD \\[ACHD\\]) with good quality of life. Despite the surgical success, the morbidity and mortality of ACHD is higher than in the general population and is linked to the development of heart failure (HF) in adulthood.\n\nHF occurs in approximately 25% of patients with ACHD, even in those patients in whom the congenital mal-formation has been corrected successfully in childhood. The time course and presentation are heterogeneous owing to variable congenital malformation and limitation of treatment options. ACHD with an anatomic right ventricle as the systemic ventricle (e.g., atrial switch operation in patients with transposition of the great arteries \\[TGAs\\]) and those with a functional single ventricle (e.g., Fontan circulation) appear to be at higher risk of developing HF. Young age at initial corrective surgery-often in the first 2 years of life-and lack of specific medical therapies can contribute to a high and early demand for heart transplantation in patients with ACHD.",[70,71,72,73,74],"Congenital Heart Disease","Heart Failure","Transplant; Complication, Failure","Arrythmia","Ventricular Dysfunction","2026-06-28",{"date":77,"type":78},"2026-07-01","ACTUAL",{"date":80,"type":78},"2020-09-02",{"date":82,"type":65},"2030-07-30",{"name":5,"class":6},1]